Takayuki Kanaseki

11PUBLICATIONS
29CO-AUTHORS
Molecular targetsTumour immunologyInnate immunityPredictive and prognostic markersBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 21, 2025
Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Sho Miyamoto, Azuna Osaki, Aiko Murai

|Feb 24, 2025
Loss of Tapasin in Tumors Potentiates T-Cell Recognition and Anti-Tumor Effects of Immune Checkpoint Blockade.

Keigo Moniwa, Serina Tokita, Toshiyuki Sumi

|Dec 10, 2024
Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer.

Minami Fusagawa, Serina Tokita, Kenji Murata

|Dec 04, 2024
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.

Tomoyuki Minowa, Kenji Murata, Yuka Mizue

|Sep 18, 2024
Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes.

Serina Tokita, Minami Fusagawa, Satoru Matsumoto

|Nov 22, 2023
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.

Asaka Wada, Yoshihiko Hirohashi, Goro Kutomi

Pageof 2

Frequent Collaborators

8 joint publications

Yoshihiko Hirohashi

5 joint publications

Tomohide Tsukahara

4 joint publications

Toshihiko Torigoe

3 joint publications

Terufumi Kubo